DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* IMMUNID *


 

2005 - Rhône-Alpes
Grenoble
www.immunid.com

 

Contract, Research
Key words: Personalized diagnostics, Combinatorial Repertoire analysis, Immunology analysis, Immunodeficiency, Immuno-monitoring, T & B cell repertoire, Genomic DNA, Infectious diseases, Auto-immune diseases, Blood cancers, Lymphoma and Leukemia diagnosis, ImmunTracker, ImmunIg
Mission: to provide third parties with innovative diagnostic and prognostic tools and high value-added services to decrease clinical study costs by selecting better immuno-drug candidates and by measuring immuno-reconstitution and suppression kinetics
Clients: Research labs, Hospitals, Pharmaceutical industry
info@immunid.com

Age: 12 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Pasqual (Nicolas) [co-founder, born 1977, Ph.D. molecular biology, ex-CEA]
Sc.Dir.-CSO: Pasqual (Nicolas)
Oper.Dir.-COO: Weisbuch (Sébastien) [born 1977, Ph.D. nanobiology, ex-CEA]
Tech.Dir.-CTO: Mouret (Jean-François) [Pharm.D., ex-Applied Biosystems, Cogenics, Genome Express (co-founder)]
Fin.Dir.-CFO:
BusDev: Plantier (Nadia)
Financers (Hist.): privately owned (registered capital 2006 = 0.053 M€)
Note : website revamped in March 2009

Turnover (M€) : 0.054 (2009), 0.08 (2008), 0.03 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Trade
Company confirm : none

 

History
DATEMILESTONETYPETIME
2011 .06 Partnering development project with Cytheris and Centre Léon Bérard (Lyon), named DivRescue for cancer management R&D [6 years]
2010 .10 Clinical trial (phase II interim) for ImmunTraCkeR and Immun'Ig in lymphoma and leukemia (beginning, RIPAL), with Prof. Gilles Salles (Lyon Hospital) CLIN [5 years]
2009 .11 Partnering development agreement with Roche Diagnostics to standardize immuno-monitoring in molecular biology R&D [4 years]
2009 .05 1st round-financing : 2.4 M€, by Vizille Capital Innovation (Vizille Capital Innovation & Sudinnova), SOFIMAC Partners and CEA Investissement RFINA [4 years]
2009 .05 Launch of Platine, a joint immuno-monitoring platform, by 5 partners (Innate Pharma, Transgene, ImmunID, Inserm and Cancer Centre Léon-Bérard), based in Lyon MKTG [4 years]
2008 .12 Financing (no interest loan) : 1.6 M€, by OSEO, to support its clinical development program of validation NDL biomarker and ImmunTraCkeR diagnostic test DEBT [3 years]
2008 .09 Licensing-in of a genomic analytical process from CEA and INSERM LICIN [3 years]
2008 .01 Partnering research agreement with Sanofi Pasteur R&D [2 years]
2007 .07 Certification : ISO 9001-2000 INFO [2 years]
2005 .03 Company founded by Nicolas Pasqual and Sébastien Weisbuch, for immunomonitoring and diagnostic solutions ORGF [0 year]

Actualisation / Updating: 27-Sep-2011

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende